Any effects of SGLT2 inhibitors on iron metabolism in CKD would be important to understand, given the high prevalence of iron deficiency and anemia in this population, especially as kidney function declines [3, 15]. The gene discussed is SLC5A2; the disease is anemia (phenotype).